Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Kyorin Pharmaceutical Co.,Ltd |
---|---|
Information provided by: | Kyorin Pharmaceutical Co.,Ltd |
ClinicalTrials.gov Identifier: | NCT00281034 |
Condition |
---|
Stroke |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS Study) |
Enrollment: | 2069 |
Study Start Date: | September 2005 |
Study Completion Date: | July 2007 |
Period:2005-2007
Observation Time:baseline, 8week, 24week
matters investigated:
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Univercity, Main hospital, general Hospital,0pen
Inclusion Criteria:
Exclusion Criteria:
Japan, Tokyo | |
Kyosai Tachikawa Hospital | |
Tachikawa-City, Tokyo, Japan, 190-8531 |
Study Chair: | Yukito Shinohara, MD | KYOSAI TACHIKAWA HOSPITAL |
Study Chair: | Yukito Shinohara, MD | KYOSAI TACHIKAWA HOSPITAL |
Study ID Numbers: | OASIS-2005, oasis-2007 |
Study First Received: | January 23, 2006 |
Last Updated: | November 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00281034 |
Health Authority: | Japan: Institutional Review Board |
brain infarction SF-36 QOL Japan 5 |
Cerebral Infarction Stroke Vascular Diseases Central Nervous System Diseases |
Brain Infarction Brain Diseases Infarction Cerebrovascular Disorders |
Nervous System Diseases Cardiovascular Diseases |